Ten New Jersey institutions collectively received $404 million in grants and contracts for biomedical research from the National Institutes of Health (NIH), which directly supported 5,136 jobs and $1.32 billion in economic activity in the state during FY23.
The data comes from United for Medical Research (UMR), a coalition of leading research institutions, patient and health advocates and private industry members that advocate for increased NIH funding.
The top NIH funded research institutions and companies in New Jersey in FY23 included:
- Rutgers Biomedical & Health Sciences (RBHS) – Cancer Institute of New Jersey
- Rutgers University
- Princeton University
- Hackensack University Medical Center
- PsychoGenics, Inc., a Paramus-based contract research organization (CRO) specializing in central nervous system (CNS) focused preclinical and translational drug discovery
- Coriell Institute for Medical Research, a leader in biobanking and biomedical research based in Camden
- Theradex Systems, Inc., a leading global contract research organization based in Princeton that has extensive expertise in oncology clinical development
- Rowan University
- New Jersey Institute of Technology
- Kessler Institute for Rehabilitation
There are 4,322 biopharmaceutical businesses in New Jersey and 104,514 employees, according to the Biotechnology Industry Association’s 2022 annual report.
